276 related articles for article (PubMed ID: 20597668)
1. Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia.
Kollef MH
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S29-35. PubMed ID: 20597668
[TBL] [Abstract][Full Text] [Related]
2. Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective.
Barriere SL
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S4-9. PubMed ID: 20597670
[TBL] [Abstract][Full Text] [Related]
3. Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design.
Niederman MS
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S12-7. PubMed ID: 20597660
[TBL] [Abstract][Full Text] [Related]
4. Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumonia.
Chastre J; Luyt CE
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S54-8. PubMed ID: 20597673
[TBL] [Abstract][Full Text] [Related]
5. Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.
Sorbello A; Komo S; Valappil T; Nambiar S
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S36-41. PubMed ID: 20597669
[TBL] [Abstract][Full Text] [Related]
6. Considerations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia.
Bradley JS
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S136-43. PubMed ID: 20597664
[TBL] [Abstract][Full Text] [Related]
7. End points in hospital-acquired pneumonia and/or ventilator-associated pneumonia clinical trials: food and drug administration perspective.
Laessig KA
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S117-9. PubMed ID: 20597659
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.
File TM
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S42-7. PubMed ID: 20597671
[TBL] [Abstract][Full Text] [Related]
9. Considerations in undertaking a clinical development program for hospital-acquired bacterial pneumonia and/or ventilator-associated bacterial pneumonia.
Talbot GH
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S144-9. PubMed ID: 20597665
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!
Ambrose PG; Bhavnani SM; Ellis-Grosse EJ; Drusano GL
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S103-10. PubMed ID: 20597657
[TBL] [Abstract][Full Text] [Related]
11. Hospital-acquired pneumonia: recent advances in diagnosis, microbiology and treatment.
Bruchhaus JD; McEachern R; Campbell GD
Curr Opin Pulm Med; 1998 May; 4(3):180-4. PubMed ID: 9675521
[TBL] [Abstract][Full Text] [Related]
12. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
Jones RN
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S81-7. PubMed ID: 20597676
[TBL] [Abstract][Full Text] [Related]
13. Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.
Torres A; Ferrer M; Badia JR
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S48-53. PubMed ID: 20597672
[TBL] [Abstract][Full Text] [Related]
14. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box.
Craven DE; Hjalmarson KI
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S59-66. PubMed ID: 20597674
[TBL] [Abstract][Full Text] [Related]
15. Scenario 1: a patient with hospital-acquired bacterial pneumonia--introduction to clinical trial design issues.
Gilbert DN
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S10-1. PubMed ID: 20597655
[TBL] [Abstract][Full Text] [Related]
16. Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumonia.
Bartlett JG; Barie PS; Niederman MS; Wunderink RG
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S1-3. PubMed ID: 20597654
[No Abstract] [Full Text] [Related]
17. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
[TBL] [Abstract][Full Text] [Related]
18. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
Kollef MH
Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
[TBL] [Abstract][Full Text] [Related]
19. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
20. The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.
Ferrer M; Menendez R; Amaro R; Torres A
Clin Chest Med; 2011 Sep; 32(3):491-505. PubMed ID: 21867818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]